NCT05991388
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05991388
Title A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma (Glo-BNHL)
Acronym Glo-BNHL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Birmingham
Indications
Therapies
Age Groups: adult | child
Covered Countries SWE | NZL | NLD | GBR | BEL | AUT | AUS

Facility Status City State Zip Country Details
The Children's Hospital at Westmead NOT_YET_RECRUITING Sydney New South Wales Australia Details
Queensland Children's Hospital NOT_YET_RECRUITING Brisbane Queensland Australia Details
Perth Children's Hospital NOT_YET_RECRUITING Perth Western Australia Australia Details
St. Anna Children's Hospital NOT_YET_RECRUITING Vienna Austria Details
UZ Leuven NOT_YET_RECRUITING Leuven Belgium Details
Princess Máxima Centre for Pediatric Oncology NOT_YET_RECRUITING Utrecht Netherlands Details
Starship Children's Hospital NOT_YET_RECRUITING Auckland New Zealand Details
Sahlgrenska University Hospital NOT_YET_RECRUITING Gothenburg Sweden Details
Birmingham Children's Hospital RECRUITING Birmingham United Kingdom Details
Bristol Royal Hospital for Children RECRUITING Bristol United Kingdom Details
Royal Manchester Children's Hospital RECRUITING Manchester United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field